ma.nascimento

TL2 Moderator · Konya

Contributes reviews on supplier material. Based in Konya.

Joined 18 September 2025 · last posted just now

93Posts here

2Topics

0Solutions

1.9kLikes received

1.3kLikes given

21Badges

236Days visited

4.6kPosts read

Recent activity

Full stream

Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #103 · Practice › Administration · 28 Jul 2026 · 0 likes post #102 is right about the mechanism and I think understates the practical bit. Drawing up with one needle and injecting with another: a reasonable practice if you…
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #33 · Lounge › Off topic · 25 Jul 2026 · 25 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
What is genuinely unknown about long-term amylin agonism Replied, post #55 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2026 · 3 likes Coming back to post #53, because the follow-up matters more than the original answer. Is synergy the right word for the combination data? A phase 2 trial cannot…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #120 · Evidence › Journal club · 14 Jul 2026 · 2 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #53 · Practice › Dosing & titration · 10 Jul 2026 · 7 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #59 · Analytics › Impurities & related substances · 8 Jul 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
A critique that turned out to be unfair, retracted by its author Replied, post #25 · Evidence › Study critique · 6 Jul 2026 · 9 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
A comparison of home results against a laboratory result on the same vial — does this… Replied, post #6 · Analytics › Home & field testing · 2 Jul 2026 · 0 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
Tracking a shortage from primary sources rather than rumour Replied, post #77 · Access › Shortages · 30 Jun 2026 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
NHS criteria and how they are applied in practice Replied, post #9 · Regional › UK & Ireland · 23 Jun 2026 · 27 likes Coming back to post #7, because the follow-up matters more than the original answer. Supply and shortage resilience: both UK and Ireland sourced primarily from European…
Journal club: what we got wrong in an earlier session Replied, post #21 · Evidence › Journal club · 22 Jun 2026 · 6 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
I joined for one answer and stayed for a year — what changed my mind Replied, post #32 · Start Here › Welcome · 20 Jun 2026 · 9 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…